Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27
- PMID: 36763251
- DOI: 10.1007/s12098-022-04414-7
Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27
Abstract
Objective: To study the serum calprotectin levels in children with juvenile idiopathic arthritis (JIA) and correlate it with C-reactive protein (CRP) and the Juvenile Arthritis Disease Activity Score-27 (JADAS-27).
Methods: This was a cross-sectional observational study done between November 2017 and March 2019. Fifty treatment-naive children, aged 1 to 18 y with the diagnosis of JIA as per the International League of Associations of Rheumatology (ILAR) criteria were enrolled. Assessment of disease activity was done according to the Juvenile Arthritis Disease Activity Score (JADAS-27). Determination of serum calprotectin and CRP levels was done by immunoassay. The correlation between calprotectin levels with CRP and JADAS-27 was calculated.
Results: Of the 50 patients with JIA included in the study, there were 18 female and 32 male children. The median age of presentation to the hospital was 9 y (IQR 5.82-13). The median JADAS-27 was 14 (IQR 6, 20.25). The median serum calprotectin level was 45,375 ng/mL (IQR 30,725, 52,270; range 8,560-63,160 ng/mL). The median CRP was 35.4 mg/L (IQR 3.48, 80.3; range 0.02 and 107.4 mg/L). The levels of calprotectin in different JIA subtypes were not statistically different using Kruskal-Wallis test. The study also demonstrated a positive correlation between serum calprotectin with CRP and the JADAS-27 (r = 0.418).
Conclusion: The calprotectin levels in JIA were significantly higher than those reported in the literature irrespective of the subtype. Serum calprotectin positively correlated with CRP and JADAS-27 in children with JIA.
Keywords: Calprotectin; Inflammation; JADAS-27; Juvenile idiopathic arthritis.
© 2022. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.
Similar articles
-
Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.Ann Rheum Dis. 2012 Jul;71(7):1122-7. doi: 10.1136/annrheumdis-2011-200237. Epub 2012 Jan 17. Ann Rheum Dis. 2012. PMID: 22258487
-
Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis.Ann Rheum Dis. 2013 Dec;72(12):1983-8. doi: 10.1136/annrheumdis-2012-202031. Epub 2012 Dec 20. Ann Rheum Dis. 2013. PMID: 23256951 Free PMC article.
-
Measurement of blood calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis.Reumatologia. 2017;55(1):10-14. doi: 10.5114/reum.2017.66682. Epub 2017 Mar 22. Reumatologia. 2017. PMID: 28386137 Free PMC article.
-
An investigation into the relationship between nutritional status, dietary intake, symptoms and health-related quality of life in children and young people with juvenile idiopathic arthritis: a systematic review and meta-analysis.BMC Pediatr. 2023 Jan 2;23(1):3. doi: 10.1186/s12887-022-03810-4. BMC Pediatr. 2023. PMID: 36593466 Free PMC article.
-
Clinical outcome measures in juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23. doi: 10.1186/s12969-016-0085-5. Pediatr Rheumatol Online J. 2016. PMID: 27089922 Free PMC article. Review.
Cited by
-
Serum Calprotectin in Juvenile Idiopathic Arthritis: A Hope or Hype?Indian J Pediatr. 2023 Dec;90(12):1167-1168. doi: 10.1007/s12098-023-04803-6. Epub 2023 Aug 17. Indian J Pediatr. 2023. PMID: 37587382 No abstract available.
-
Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis.BMC Pediatr. 2025 Mar 27;25(1):242. doi: 10.1186/s12887-025-05594-9. BMC Pediatr. 2025. PMID: 40148850 Free PMC article. Clinical Trial.
References
-
- Sawhney S, Woo P. Diagnosis and management of juvenile idiopathic arthritis: current status. Indian Pediatr. 2001;38:1083–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous